非酒精性脂肪性肝病中超声剪切波与瞬态弹性成像的可重复性与重复性研究
这项前瞻性观察性横断面研究于2021年3月至11月在两个中心纳入40例非酒精性脂肪性肝病患者,按FIB-4指数分层,评估五种超声剪切波弹性成像系统和一种振动控制瞬态弹性成像系统的测量变异。剪切波弹性成像的跨天跨操作者可重复性系数为30.7%,达到预设的低于35%的性能阈值,而振动控制瞬态弹性成像为35.6%;剪切波弹性成像在不同系统间的变异更高。
要点
- 剪切波弹性成像跨天跨操作者可重复性系数30.7%,达到预设低于35%的性能阈值。
- 振动控制瞬态弹性成像跨天跨操作者可重复性系数35.6%,高于剪切波弹性成像。
- 剪切波弹性成像不同系统间同日同操作者可重复性系数为52.7%,系统间变异更高。
核心结论
- 剪切波弹性成像达到预设阈值(跨天跨操作者可重复性系数低于35%),振动控制瞬态弹性成像的可重复性系数更高;剪切波弹性成像在不同系统间的变异更高。
研究设计与样本
- 前瞻性观察性横断面研究,2021年3月至2021年11月在两个中心纳入40例非酒精性脂肪性肝病成人,按FIB-4指数(≤1.3、>1.3且<2.67、≥2.67)分层,评估五种超声剪切波弹性成像系统和一种振动控制瞬态弹性成像系统。
诊断标准与关键数值
- 剪切波弹性成像跨天跨操作者可重复性系数为30.7%(95%上限34.4%),振动控制瞬态弹性成像为35.6%(95%上限43.9%),预设性能阈值为低于35%。
- 剪切波弹性成像系统特异性的跨天跨操作者可重复性系数范围为24.2%至34.3%。
- 剪切波弹性成像同日同操作者重复性系数为21.0%(范围13.9%至35.0%),振动控制瞬态弹性成像为19.6%。
- 剪切波弹性成像不同系统间同日同操作者可重复性系数为52.7%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background US shear-wave elastography (SWE) and vibration-controlled transient elastography (VCTE) enable assessment of liver stiffness, an indicator of fibrosis severity. However, limited reproducibility data restrict their use in clinical trials. Purpose To estimate SWE and VCTE measurement variability in nonalcoholic fatty liver disease (NAFLD) within and across systems to support clinical trial diagnostic enrichment and clinical interpretation of longitudinal liver stiffness. Materials and Methods This prospective, observational, cross-sectional study (March 2021 to November 2021) enrolled adults with NAFLD, stratified according to the Fibrosis-4 (FIB-4) index (≤1.3, >1.3 and <2.67, ≥2.67), at two sites to assess SWE with five US systems and VCTE with one system. Each participant underwent 12 elastography examinations over two separate days within 1 week, with each day's examinations conducted by a different operator. VCTE and SWE measurements were reported in units of meters per second. The primary end point was the different-day, different-operator reproducibility coefficient (RDCDDDO) pooled across systems for SWE and individually for VCTE. Secondary end points included system-specific RDCDDDO, same-day, same-operator repeatability coefficient (RCSDSO), and between-system same-day, same-operator reproducibility coefficient. The planned sample provided 80% power to detect a pooled RDCDDDO of less than 35%, the prespecified performance threshold. Results A total of 40 participants (mean age, 60 years ± 10 [SD]; 24 women) with low (n = 17), intermediate (n = 15), and high (n = 8) FIB-4 scores were enrolled. RDCDDDO was 30.7% (95% upper bound, 34.4%) for SWE and 35.6% (95% upper bound, 43.9%) for VCTE. SWE system-specific RDCDDDO varied from 24.2% to 34.3%. The RCSDSO was 21.0% for SWE (range, 13.9%-35.0%) and 19.6% for VCTE. The SWE between-system same-day, same-operator reproducibility coefficient was 52.7%. Conclusion SWE met the prespecified threshold, RDCDDDO less than 35%, with VCTE having a higher RDCDDDO. SWE variability was higher between different systems. These estimates advance liver US-based noninvasive test qualification by (a) defining expected variability, (b) establishing that serial examination variability is lower when performed with the same system, and (c) informing clinical trial design. ClinicalTrials.gov Identifier NCT04828551 © RSNA, 2024 Supplemental material is available for this article.
引用
- Pierce TT, Ozturk A, Sherlock SP, et al. Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease. Radiology. 2024. PMID: 39254458. doi:10.1148/radiol.233094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。